UBS Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-263,403
| Closed | -$4.73M | – | 7329 |
|
2017
Q4 | $4.73M | Buy |
263,403
+224,460
| +576% | +$4.03M | ﹤0.01% | 1884 |
|
2017
Q3 | $460K | Buy |
38,943
+12,619
| +48% | +$149K | ﹤0.01% | 3503 |
|
2017
Q2 | $276K | Sell |
26,324
-4,445
| -14% | -$46.6K | ﹤0.01% | 3717 |
|
2017
Q1 | $339K | Sell |
30,769
-21,847
| -42% | -$241K | ﹤0.01% | 3519 |
|
2016
Q4 | $713K | Buy |
52,616
+22,749
| +76% | +$308K | ﹤0.01% | 3072 |
|
2016
Q3 | $368K | Buy |
29,867
+25,900
| +653% | +$319K | ﹤0.01% | 3340 |
|
2016
Q2 | $44K | Buy |
3,967
+2,351
| +145% | +$26.1K | ﹤0.01% | 4763 |
|
2016
Q1 | $18K | Sell |
1,616
-1,294
| -44% | -$14.4K | ﹤0.01% | 5467 |
|
2015
Q4 | $50K | Sell |
2,910
-10,756
| -79% | -$185K | ﹤0.01% | 4757 |
|
2015
Q3 | $271K | Buy |
13,666
+12,750
| +1,392% | +$253K | ﹤0.01% | 3511 |
|
2015
Q2 | $15K | Hold |
916
| – | – | ﹤0.01% | 5725 |
|
2015
Q1 | $14K | Buy |
916
+280
| +44% | +$4.28K | ﹤0.01% | 5679 |
|
2014
Q4 | $9K | Buy |
+636
| New | +$9K | ﹤0.01% | 6077 |
|